We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multi-Bay Modular Real Time PCR Instrument Enables Rapid Onsite Nucleic Acid Testing

By LabMedica International staff writers
Posted on 02 Nov 2023

A new generation of compact and inexpensive molecular testing platforms features a unique ultra-low-light CMOS sensor technology that enables the detection of infectious or oncology markers, as well as pathogens in the food and environment. More...

Anitoa Systems (Sunnyvale, CA, USA) has launched new 96-well multi-bay modular real-time PCR (qPCR) instruments in its Maverick line of qPCR products. Anitoa's Maverick multi-bay modular qPCR instrument MQx96 is the company’s first larger format qPCR instrument that comes with multiple independently operable modules. The MQx96 and MQx48 instruments are available in 96 (6X16) and 48 (3X16) well formats, and feature 6X or 3X 16-well qPCR modules, both of which can be independently controlled using a unified software interface. MQx96 is ideal for laboratories that are required to run small sample batches continuously in a pipelined manner.

Maverick qPCR instruments feature technological innovations, including a unique proprietary low-light complementary metal-oxide-semiconductor (CMOS) 4-channel fluorescence optics system that enables rapid and highly multiplexed DNA detection. Additionally, Maverick qPCR instruments are easy to use and do not need calibration, thanks to their solid-state construction. Apart from their operational flexibility, Anitoa's MQ96 (and MQ48) are modular systems with each reaction chamber independently heated and cooled. This enables the instruments to achieve a 30-40% faster reaction time compared to traditional large-block qPCR systems.

"We are excited to offer laboratories worldwide a modular solution for rapid and pipelined nucleic acid tests to help combat diseases by detecting pathogens in human, as well as our food and environment," said Dr. Zhimin Ding, CEO of Anitoa Systems. "We believe our multi-bay modular qPCR instruments and the integrated software offer features that meet the needs of labs seeking higher throughput testing while being extremely flexible."

Related Links:
Anitoa Systems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
Pipette
Accumax Smart Series
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.